Yue Shi
- Hematology top 2%
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 7
- Cancer Genomics and Diagnostics 5
- Molecular Biology top 5%
- RNA modifications and cancer 11
- Epigenetics and DNA Methylation 9
- Cancer-related gene regulation 5
- Genetics top 5%
- Oncology top 5%
-
- Bladder and Urothelial Cancer Treatments 8
-
- Renal cell carcinoma treatment 7
- Co-authors
- Michael AndreeffMarina KonoplevaZhihong ZengWeimin CiXiaoyang LingMark J. LevisRui-Yu WangJoshua B. Rubin
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yue Shi
85 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Hematology 404
- Cancer Research 520
- Molecular Biology 1.4k
- Genetics 211
- Oncology 517
Countries citing papers authored by Yue Shi
This map shows the geographic impact of Yue Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Shi more than expected).
Fields of papers citing papers by Yue Shi
This network shows the impact of papers produced by Yue Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Shi. The network helps show where Yue Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yue Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 69 | |
| 8 | Multispecies forest plantations outyield monocultures across a broad range of conditionsbreakdown → | 2022 | 252 |
| 9 | 2022 | 18 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 31 | |
| 13 | 2021 | 7 | |
| 14 | 2020 | 6 | |
| 15 | 2020 | 6 | |
| 16 | 2020 | 2 | |
| 17 | 2020 | 14 | |
| 18 | 2020 | 107 | |
| 19 | 2016 | 9 | |
| 20 | 2008 | 397 |
About Yue Shi
Yue Shi is a scholar working on Cancer Research, Nephrology and Pulmonary and Respiratory Medicine, having authored 93 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (11 papers), Epigenetics and DNA Methylation (9 papers), Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (7 papers), MicroRNA in disease regulation (7 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related gene regulation (5 papers). The work is most often cited by research in Hematology (404 citations), Cancer Research (520 citations) and Molecular Biology (1.4k citations). Yue Shi has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Michael Andreeff, Marina Konopleva, Zhihong Zeng, Weimin Ci, Xiaoyang Ling, Mark J. Levis, Rui-Yu Wang, Joshua B. Rubin, Elihu H. Estey and Sergej Konoplev. Their work appears in journals such as Nature Communications, Cancer Management and Research, Blood, Clinical Epigenetics and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.